March 26th, 2019 by admin | May 12, 2022 | News | 0 comments SonoMotion receives Health Canada ITA approval to initiate its Break WaveTM First-In-Human clinical trial in Canada. Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Recent Comments